Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27660060 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL7941251 | 1.00 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL28480096 | 0.88 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL237016 | 0.88 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL28992579 | 0.88 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL28899840 | 0.88 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL465120 | 0.88 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL29184904 | 0.88 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL873751 | 0.88 | CA2 (0.46) | — | |
| Phosphoric Acid SCHEMBL28992587 | 0.88 | CA2 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4269536-B1 | FIRE-RETARDANT ORIENTED STRAND BOARD (OSB) | ARXADA LLC (US) | 2025-11-26 | — | — | EP | claimed |
| US-12286579-B2 | Fire-retardant oriented strand board | Arxada, LLC (US) | 2025-04-29 | — | — | US | claimed |
| EP-4269536-A2 | FIRE-RETARDANT ORIENTED STRAND BOARD (OSB) | Arxada, LLC (US) | 2023-11-01 | — | — | EP | claimed |
| EP-3983187-B1 | FIRE-RETARDANT ORIENTED STRAND BOARD (OSB) | ARXADA LLC (US) | 2023-08-23 | — | — | EP | claimed |
| US-20220340816-A1 | Fire-Retardant Oriented Strand Board | Arxada, LLC | 2022-10-27 | — | — | US | claimed |
| US-11414602-B2 | Fire-retardant oriented strand board | Arxada, LLC (US) | 2022-08-16 | — | — | US | claimed |
| EP-3983187-A1 | FIRE-RETARDANT ORIENTED STRAND BOARD (OSB) | Arxada, LLC (US) | 2022-04-20 | — | — | EP | claimed |
| CN-114323878-A | Formalin fixation method for liver micronucleus test | 上海益诺思生物技术股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114340860-A | Flame-retardant Oriented Strand Board (OSB) | 阿尔萨达有限责任公司 | 2022-04-12 | — | — | CN | claimed |
| US-11035763-B2 | Kit for producing cleared biological specimens and method for producing cleared biological specimens | KANAZAWA MEDICAL UNIVERSITY (JP) | 2021-06-15 | — | — | US | claimed |
| CN-106834208-B | Ultrasonic disruption method of naked mole tissue in chromatin co-immunoprecipitation | 中国人民解放军第二军医大学 | 2021-05-07 | — | — | CN | claimed |
| CN-106834208-A | The ultrasonication method of naked mole tissue in chromatin immune co-precipitation | 中国人民解放军第二军医大学 | 2017-06-13 | — | — | CN | claimed |
| CN-106255759-A | Enzymatic production of acetyl phosphate from formaldehyde | 财富科学家股份有限公司 | 2016-12-21 | — | — | CN | claimed |
| CN-102960309-A | Minipig chronic pulmonary hypertension animal model and construction method thereof | FIRST AFFILIATED HOSPITAL GUANGZHOU MEDICAL SCHOOL | 2013-03-13 | — | — | CN | claimed |
| EP-1580320-B1 | Compositions for porous materials | NAVARRINI WALTER (IT) | 2009-05-27 | — | — | EP | claimed |
| EP-1580320-A2 | Compositions for porous materials | Navarrini, Walter (IT) | 2005-09-28 | — | — | EP | claimed |
| CN-1052632-C | Slow-calcifying compound epoxy cross-linking method for collagen tissue material | UNIV CHENGDU (CN) | 2000-05-24 | — | — | CN | claimed |
| CN-1093566-A | Slow-calcifying compound epoxy cross-linking method for collagen tissue material | UNIV CHENGDU (CN) | 1994-10-19 | — | — | CN | claimed |
| US-12582689-B2 | Use of terpenoids in the treatment or prevention of fibrotic diseases | Arjil Biotech Holding Company Limited (TW) | 2026-03-24 | — | — | US | disclosed |
| US-4359527-A | Cancer diagnostic assay | THE CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1982-11-16 | — | — | US | disclosed |